Brilique 90 mg film-coated tablets
Sponsors
Rigshospitalet, St Antonius Hospital, Wellbeing Services County Of North Karelia Siun Sote, Weill Medical College Of Cornell University, Centre Hospitalier Universitaire De Caen Normandie
Conditions
Acute Coronary Syndrome and Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary InterventionAcute Myocardial InfarctionCARDIOVASCULAR DISEASESChronic coronary syndromeCoronary artery diseaseElderly patients ≥ 65 years successfully treated with percutaneous coronary intervention (PCI) with ≥ 1 drug-eluting stent for acute or chronic coronary syndromeMyocardial infarctionPatients with coronary artery disease and an indication for PCI
Phase 2
Phase 3
VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome (VERONICA)
Not yet recruitingCTIS2024-512436-29-00
Target: 634Updated: 2024-04-03
The One-Month DAPT with Ticagrelor In CABG PatieNts Trial (ODIN)
RecruitingCTIS2023-506613-22-00
Start: 2024-09-25Target: 300Updated: 2026-01-19
Dual Antithrombotic Therapy with Dabigatran and Ticagrelor in Patients with Acute Coronary Syndrome and Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention (ADONIS-PCI)
CompletedCTIS2024-515056-20-00
Start: 2021-07-31End: 2025-10-31Target: 2230Updated: 2025-04-01
Phase 4
Reduced antithrombotic strategy for high bleeding risk patients with myocardial infarction treated with percutaneous coronary intervention - The Dan-DAPT trial
RecruitingCTIS2022-500125-32-00
Start: 2022-06-20Target: 2700Updated: 2025-11-18
Pharmacodynamic Outcomes in patients with coronary artery disease undergoing Percutaneous coronary intervention treated with an individualized treatment STRATEGY (POPular STRATEGY PD)
RecruitingCTIS2023-504078-39-01
Start: 2024-01-11Target: 88Updated: 2024-08-26
Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI (DEBATE)
RecruitingCTIS2023-504340-34-01
Start: 2024-01-11Target: 734Updated: 2025-06-26
PhARMacodynamics of earlY versus Delayed Administration of TIcagrelor during CAngrelor infusion in patients with acute ST-segment elevation Myocardial Infarction: a randomized superiority study
Not yet recruitingCTIS2024-511944-18-01
Target: 50Updated: 2024-08-13
COATS (genetic Clopidogrel response testing to finetune the antithrombotic regimen in (D)OAC Treated patients undergoing PCI) Study
Not yet recruitingCTIS2024-512350-17-01
Target: 520Updated: 2024-09-13
Evaluation of a modified Anti-Platelet Therapy associated with low-dose rapamycin DES Firehawk in
Acute Myocardial Infarction Patients treated with complete revascularization strategy (TARGET-FIRST)
CompletedCTIS2024-519854-35-00
Start: 2021-06-29End: 2025-03-24Target: 695Updated: 2025-04-14
Safety and efficacy of very short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy in older patients undergoing percutaneous coronary intervention.
Not yet recruitingCTIS2023-507545-28-00
Target: 1700Updated: 2025-03-27